1
|
Yu C, Chen K, Zheng H, et al:
Overexpression of astrocyte elevated gene-1 (AEG-1) is associated
with esophageal squamous cell carcinoma (ESCC) progression and
pathogenesis. Carcinogenesis. 30:894–901. 2009. View Article : Google Scholar : PubMed/NCBI
|
2
|
Mohebbi M, Mahmoodi M, Wolfe R, et al:
Geographical spread of gastrointestinal tract cancer incidence in
the Caspian Sea region of Iran: spatial analysis of cancer registry
data. BMC Cancer. 8:1372008. View Article : Google Scholar : PubMed/NCBI
|
3
|
Gong T, Xue Z, Tang S, et al: Nuclear
expression of Twist promotes lymphatic metastasis in esophageal
squamous cell carcinoma. Cancer Biol Ther. 13:606–613. 2012.
View Article : Google Scholar : PubMed/NCBI
|
4
|
Tang S, Gao L, Bi Q, et al: SDR9C7
promotes lymph node metastases in patients with esophageal squamous
cell carcinoma. PLoS One. 8:e521842013. View Article : Google Scholar : PubMed/NCBI
|
5
|
Xu G, Tang S, Yang J, et al: BMP7
expression in esophageal squamous cell carcinoma and its potential
role in modulating metastasis. Dig Dis Sci. 58:1871–1879. 2013.
View Article : Google Scholar : PubMed/NCBI
|
6
|
Meng Y, He L, Guo X, et al: Gankyrin
promotes the proliferation of human pancreatic cancer. Cancer Lett.
297:9–17. 2010. View Article : Google Scholar : PubMed/NCBI
|
7
|
Tang S, Yang G, Meng Y, et al:
Overexpression of a novel gene gankyrin correlates with the
malignant phenotype of colorectal cancer. Cancer Biol Ther.
9:88–95. 2010. View Article : Google Scholar
|
8
|
Fu J, Chen Y, Cao J, et al: p28GANK
overexpression accelerates hepatocellular carcinoma invasiveness
and metastasis via phos-phoinositol 3-kinase/AKT/hypoxia-inducible
factor-1α pathways. Hepatology. 53:181–192. 2011. View Article : Google Scholar : PubMed/NCBI
|
9
|
Zhen C, Chen L, Zhao Q, et al: Gankyrin
promotes breast cancer cell metastasis by regulating Rac1 activity.
Oncogene. 32:3452–3460. 2013. View Article : Google Scholar
|
10
|
Li J, Knobloch TJ, Kresty LA, et al:
Gankyrin, a biomarker for epithelial carcinogenesis, is
overexpressed in human oral cancer. Anticancer Res. 31:2683–2692.
2011.PubMed/NCBI
|
11
|
Yang Y, Zhang C, Li L, et al: Up-regulated
oncoprotein P28GANK correlates with proliferation and poor
prognosis of human glioma. World J Surg Oncol. 10:1692012.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Gao L, Xie H, Dong L, et al: Gankyrin is
essential for hypoxia enhanced metastatic potential in breast
cancer cells. Mol Med Rep. 9:1032–1036. 2014.
|
13
|
Wang G, Rong J, Zhou Z and Duo J: Novel
gene P28GANK confers multidrug resistance by modulating the
expression of MDR-1, Bcl-2 and Bax in osteosarcoma cells. Mol Biol
(Mosk). 44:1010–1017. 2010. View Article : Google Scholar
|
14
|
Ortiz CM, Ito T, Tanaka E, et al: Gankyrin
oncoprotein overexpression as a critical factor for tumor growth in
human esophageal squamous cell carcinoma and its clinical
significance. Int J Cancer. 122:325–332. 2008. View Article : Google Scholar
|
15
|
Bi Q, Tang S, Xia L, et al: Ectopic
expression of MiR-125a inhibits the proliferation and metastasis of
hepatocellular carcinoma by targeting MMP11 and VEGF. PLoS One.
7:e401692012. View Article : Google Scholar : PubMed/NCBI
|
16
|
Higashitsuji H, Higashitsuji H, Itoh K, et
al: The oncoprotein gankyrin binds to MDM2/HDM2, enhancing
ubiquitylation and degradation of p53. Cancer Cell. 8:75–87. 2005.
View Article : Google Scholar : PubMed/NCBI
|
17
|
Lozano G and Zambetti GP: Gankyrin: an
intriguing name for a novel regulator of p53 and RB. Cancer Cell.
8:3–4. 2005. View Article : Google Scholar : PubMed/NCBI
|
18
|
Qian YW, Chen Y, Yang W, et al: p28(GANK)
prevents degradation of Oct4 and promotes expansion of
tumor-initiating cells in hepatocarcinogenesis. Gastroenterology.
142:1547–1558. 2012. View Article : Google Scholar : PubMed/NCBI
|
19
|
Chu YW, Yang PC, Yang SC, et al: Selection
of invasive and metastatic subpopulations from a human lung
adenocarcinoma cell line. Am J Respir Cell Mol Biol. 17:353–360.
1997. View Article : Google Scholar : PubMed/NCBI
|
20
|
Tie J, Pan Y, Zhao L, et al: MiR-218
inhibits invasion and metastasis of gastric cancer by targeting the
Robo1 receptor. PLoS Genet. 6:e10008792010. View Article : Google Scholar : PubMed/NCBI
|
21
|
Bai ZF, Tai Y, Li W, et al: Gankyrin
activates IL-8 to promote hepatic metastasis of colorectal cancer.
Cancer Res. 73:4548–4558. 2013. View Article : Google Scholar : PubMed/NCBI
|
22
|
Mine H, Sakurai T, Kashida H, et al:
Association of gankyrin and stemness factor expression in human
colorectal cancer. Dig Dis Sci. 58:2337–2344. 2013. View Article : Google Scholar : PubMed/NCBI
|
23
|
Zhen C, Chen L, Zhao Q, et al: Gankyrin
promotes breast cancer cell metastasis by regulating Rac1 activity.
Oncogene. 32:3452–3460. 2013. View Article : Google Scholar
|